Course Description:USP Biologics is pleased to kick off a series of webinars to keep you up to date on current trends, USP initiatives and opportunities for stakeholders to impact public health standards. The first event will be held on May 19, 2020, with subsequent events approximately 4 months apart. Each event will be hosted live first so that participants can submit questions to the speaker(s); it will then be posted for on-demand viewing later. Due to the COVID-19 pandemic and our essential role in supporting public health, USP has assigned significant resources to supporting development, manufacturing, and to maintaining supply chain integrity in collaboration with many stakeholders. This first webinar will share some of the needs we’ve uncovered and the lessons we’ve learned as a result of our public outreach. USP standards that support vaccine development and monoclonal antibody characterization will be reviewed along with tools supporting this work.
For this topic and future ones, we hope to engage attendees who are subject matter experts so that they can participate in content development and share in the future as we build a supportive community.
.
By taking this course, you will be able to:
- Identify USP staff and resources that can support analytical method development and validation for COVID-19 therapeutics, vaccines and related biologics
- Describe trends and needs for future COVID-19 innovation
- Identify USP standards that support development and characterization of vaccines and monoclonal antibodies
Who should participate:
- Lab personnel in research and development, manufacturing and production
- Scientists and managers of manufacturing and contract research organizations
- Quality assurance and quality control specialists and auditors
- Regulatory professionals